AFP and hepatocellular carcinoma: Traditional markers, including microvascular invasion, alpha-fetoprotein (AFP), tumor stage, and inflammation-related prognostic markers, have been used for a long time to predict the prognosis of patients with HCC (Kong et al., 2020c; Kong et al., 2021a; Kong et al., 2021b; Boilève et al., 2021).